Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
tags : Trial crawled date : 2022 - 02 - 23 save search
Parker Scheduled to Present at the Evercore ISI Industrial Conference on February 28 at 9:40 a.m. Eastern Time
Published: 2022-02-23 (Crawled : 22:00) - globenewswire.com
PH | $540.57 -0.66% 0.0% 510K
|
Producer Manufacturing
|
| O: -2.24%
H: 2.32%
C: 2.03%
trial conference
Horizon Therapeutics plc Initiates Phase 3 Clinical Trial (OPTIC-J) in Japan Evaluating Teprotumumab for the Treatment of Active Thyroid Eye Disease (TED)
Published: 2022-02-23 (Crawled : 19:00) - biospace.com/
HZNP | $116.3 0.03% 29M
|
Health Technology
|
| O: 0.97%
H: 0.38%
C: -2.35%
treatment eye eye disease trial therapeutics disease active phase 3
MyMD Pharmaceuticals Enrolls First Patient in Phase 2 Clinical Trial of MYMD-1 as a Therapy for Delaying Aging and Extending Healthy Lifespan
Published: 2022-02-23 (Crawled : 18:00) - biospace.com/
MYMD | $2.1 0.0% 45K
|
Manufacturing
|
| O: 0.49%
H: 2.91%
C: -9.93%
health phase 2 als trial therapy enroll
Cytokinetics Announces Start of SEQUOIA-HCM, a Phase 3 Clinical Trial of Aficamten in Patients With Symptomatic Obstructive Hypertrophic Cardiomyopathy
Published: 2022-02-23 (Crawled : 13:30) - biospace.com/
CYTK | $67.94 -1.54% -1.56% 1.3M
|
Health Technology
|
| O: 0.0%
H: 1.25%
C: -6.95%
cardio trial star phase 3
Industry Leaders to Come Together to Advance Digital Trials at Veeva TMF Innovation Forum
Published: 2022-02-23 (Crawled : 12:30) - prnewswire.com
VEEV | News | $199.2 -0.58% 0.0% 1M
|
Technology Services
|
| O: 0.77%
H: 0.2%
C: -4.42%
als trials trial
Otis to Attend Barclays Industrial Select Conference
Published: 2022-02-23 (Crawled : 12:30) - prnewswire.com
OTIS | $94.96 -1.06% 0.0% 2.3M
|
Producer Manufacturing
|
| O: 0.62%
H: 0.04%
C: -2.71%
trial conference
Follow Live Today: CNH Industrial Capital Markets Day
Published: 2022-02-22 (Crawled : 00:00) - globenewswire.com
CNHI | News | $12.36 -1.51% -0.08% 8M
|
Producer Manufacturing
|
| O: -3.95%
H: 2.88%
C: -1.13%
day trial oda
CNH Industrial Ventures established to accelerate new technology adoption and nurture disruptive innovation
Published: 2022-02-22 (Crawled : 00:00) - globenewswire.com
CNHI | News | $12.36 -1.51% -0.08% 8M
|
Producer Manufacturing
|
| O: -3.95%
H: 2.88%
C: -1.13%
technology trial cel new technology
Marinus Pharmaceuticals Announces Delay to RAISE Phase 3 Clinical Trial in Status Epilepticus and Associated IV Ganaxolone Clinical Trials
Published: 2022-02-22 (Crawled : 00:00) - biospace.com/
MRNS | $1.45 20.83% 17.24% 10M
|
Health Technology
|
| O: -1.16%
H: 2.26%
C: 0.99%
epilepticus als trials trial one clinical trials phase 3
Gainers vs Losers
| 56% | 44% |
Top 10 Gainers
INVO | $1.76 131.58% 56.82% 230M
|
Health Technology
SINT | $0.0365 59.39% 37.26% 470M
|
Health Technology
WISA 4 | $9.19 50.66% 33.7% 65M
|
Electronic Technology
EDBL | News | $6.73 47.91% 32.39% 13M
|
GCTK | $0.715 36.27% 26.62% 640K
|
Manufacturing
TCON | $2.33 36.26% 26.61% 2M
|
Health Technology
TIRX | $0.48 6.43% 24.58% 4.8M
|
KZIA | $0.38 30.58% 23.42% 300K
|
Health Technology
VNDA | News | $5.23 29.14% 22.56% 24M
|
Health Technology
ATNF | $1.91 29.05% 22.51% 310K
|
Your saved searches
Save your searches and get alerts when important news are released.